Search clinical trials for: FDG-PET

Total 7220 results

Washington University School of Medicine

Terminated

FDG Tumor Heterogeneity During Chemoradiation as a Predictor of Response in Patients With Cervical Cancer

Cervical Cancer | Uterine Cervical Neoplasms | Uterine Cervical Cancer

United States
Marco Picardi
Federico II University

Unknown

Prospective Comparison Between FDG-PET/MR and FDG-PET/CT in Classical Hodgkin Lymphoma and DLBC Non-Hodgkin Lymphoma

Classical Hodgkin Lymphoma | Diffuse Large B-cell-lymphoma

Italy
University of Utah
National Cancer Institute (NCI)

Completed

Fluorodeoxyglucose (FDG)-Positron Emission Tomography (PET) in Cancer Associated Venothromboembolism

Venothromboembolism

United States
University Hospital, Ghent

Completed

A Feasibility Study On Continuous Adaptive [18f]Fdg-Pet-Guided Radiotherapy For Head and Neck Cancer

Squamous Cell Carcinoma

Belgium
Region Västerbotten
Umeå University

Recruiting

Prognostic and Diagnostic Added Value of Medical Imaging in Gynecological Cancer (PRODIGYN) (PRODIGYN)

Cervix Cancer | Endometrial Cancer | Epithelial Ovarian Cancer

Sweden
IRCCS San Raffaele

Completed

Study of Cerebral Glucose Metabolism in Neurodegenerative Diseases and Head Trauma

Neurodegenerative Diseases
King Faisal Specialist Hospital & Research Center

Completed

Use of FDG PET as Predictor of Residual Disease and Subsequent Relapse in Patients With NHL and HD Undergoing HDC and ASCT

Lymphoma, Non-Hodgkin | Hodgkin Disease
Medanta Institute of Clinical Research

Unknown

A Comparison of FDG-PET Versus MRI Based Target Volume Delineation in Glioblastoma and the Role of FDG-PET/CT in the Alteration of MRI Based Target Volumes.

Glioblastoma
National Taiwan University Hospital

Recruiting

The Brain Metabolic Change in Chronic Cancer Pain Patient: FDG PET Image Study

Cancer Pain

Taiwan
Washington University School of Medicine
Cystic Fibrosis Foundation

Completed

FDG-PET Imaging in Young Cystic Fibrosis Patients

Cystic Fibrosis

United States
Gruppo Italiano Studio Linfomi
Registro Tumori di Modena; Registro Tumori di Reggio Emilia; Registro Tumori... and other collaborators

Completed

The Use of FDG-PET in Patient With Hodgkin Lymphoma: a Population Based Study From Northern Italy

Histologically Confirmed Classical Hodgkin Lymphoma According to the Current World Health Organisation Classification

Italy
Assistance Publique - Hôpitaux de Paris

Not yet recruiting

Impact of Confirmed Autoimmune Encephalitis on Brain Glucose Metabolism (ENCEPHATAIP)

Autoimmune Encephalitis

France
University of Milano Bicocca

Recruiting

FDG-PET in the Diagnosis of Autoimmune Encephalitis (PEA)

Autoimmune Encephalitis

Italy
Centre Oscar Lambret
Ministry of Health, France

Completed

Early Assessment of the Response to Neo-adjuvant Chemotherapy in Breast Cancer Patients With FDG-PET (CHIMTEP)

Breast Cancer

France
Duke University

Recruiting

Intratreatment FDG-PET During Radiation Therapy for Gynecologic and Gastrointestinal Cancers

Esophageal Cancer | Vulvar Cancer | Anal Canal Cancer | Cancer of the Cervix

United States
University of Oklahoma
Midwest Medical Isotopes

Terminated

Assessment of Hematopoietic Recovery Following Chemotherapy for Non-Hodgkin's Lymphoma

Non-Hodgkin's Lymphoma

United States
Norwegian University of Science and Technology
University Hospital of North Norway; University of Bergen; St. Olavs Hospital

Recruiting

The EMINENCE Study - PET/MR Imaging of Head Neck Cancer (EMINENCE)

Head and Neck Neoplasms

Norway
Washington University School of Medicine

Terminated

PET/MR for Rectal Cancer Treatment Monitoring and Surveillance

Rectal Cancer | Cancer of the Rectum

United States
Jules Bordet Institute

Completed

PET Evaluation of Response After 1 Course of Chemotherapy as Predictor of Treatment Outcome. (earlyPETmCRC)

Colorectal Cancer Metastatic | Early Response Evaluation | Fdg-PET

Belgium
Jewish General Hospital

Recruiting

FDG Digital PET/CT as First Line Investigation for Giant Cell Arteritis

Vasculitis | Giant Cell Arteritis

Canada
Institute of Oncology Ljubljana
University of Ljubljana

Unknown

FDG PET/CT Radiomics Analyses of Lung Cancer Patients Treated With Immunotherapy

Correlation of iRADIOMICS and irRC With Survival

Slovenia
Centre Hospitalier Universitaire Saint Pierre

Completed

PET/CT in Extrapulmonary TB in HIV Patients: a Clinical Trial

Extrapulmonary Tuberculosis in HIV Patients
Merck Sharp & Dohme LLC

Completed

A Study to Assess Regional Cerebral Blood Flow as an Alzheimer's Disease Biomarker Compared to Positron Emission Tomography in Patients With Mild-to-Moderate Alzheimer's Disease and Cognitively Normal Elderly Subjects (Study MK-0000-068)(COMPLETED)

Alzheimer's Disease
Abramson Cancer Center at Penn Medicine

Active, not recruiting

FDG PET/CT in Lung Cancer Staging

Non-Small Cell Lung Cancer (NSCLC)

United States
University of Zurich

Withdrawn

Prospective Evaluation of the Preoperative Lymph Node Staging in Patients With Cancer of the Esophagogastric Junction and Stomach

Adenocarcinoma | Stomach Cancer | Cancer of Esophagogastric Junction

Switzerland
Rabin Medical Center

Unknown

Evaluation of PET CT in the Management of Patients With Crohn's Disease.

Crohn's Disease

Israel
Université de Sherbrooke

Unknown

Use of FDG PET/CT to Evaluate Crohn Disease

Crohn Disease

Canada
Peking University

Unknown

Explore the Clinical Value of 68Ga-DOTANOC PET/CT and 18F-FDG PET/CT in Neuroendocrine Neoplasms

Neuroendocrine Tumors

China
Case Comprehensive Cancer Center
National Cancer Institute (NCI)

Completed

NaF PET/MRI Evaluation for Bone Metastases in Breast Cancer

Malignant Neoplasm of Breast TNM Staging Distant Metastasis (M) | Untreated Bone Metastases

United States
Peter MacCallum Cancer Centre, Australia
Melbourne Health; Westmead Hospital; Victorian Infectious Diseases Reference...

Completed

PET/CT and Bacterial/Fungal PCR in High Risk Febrile Neutropenia (PIPPIN)

Acute Myeloid Leukemia | Febrile Neutropenia | Acute Lymphoblastic Leukemia | Haematopoietic Stem Cell Transplant, Autologous | Haematopoietic Stem Cell Transplant, Allogeneic

Australia
Tim Lau
McGill University

Not yet recruiting

Implementation and Evaluation of Improved Access to Medical Imaging for Geriatric Patients of The Royal Ottawa Hospital

Cognitive Impairment | Dementia | Dementia With Lewy Bodies
Jules Bordet Institute
Eli Lilly and Company

Completed

Multiorgan Metabolic Imaging Response Assessment of Abemaciclib (MiMe-A)

Cholangiocarcinoma | Endometrial Cancer | Esophageal Adenocarcinoma | Urothelial/Bladder Cancer, Nos | Esophagus SCC

France, Belgium
University of Pennsylvania

Completed

PET/CT in Psoriatic Arthritis

Psoriatic Arthritis

United States
Centre Francois Baclesse

Completed

Contribution of the Imaging to the Expression of intégrines αvβ3 for the Characterization of Residual Masses of Non-seminoma Tumors at the End of Chemotherapy (TERMATEP)

Metastasis | Non-seminomatous Germ Cell Tumors

France
Odense University Hospital

Unknown

Dual PET/CT Imaging in Lung Cancer (DILUCE)

Lung Cancer

Denmark
Odense University Hospital

Active, not recruiting

Molecular Evaluation in Metastatic Breast Cancer (MESTAR)

Metastatic Breast Cancer | Molecular Imaging

Denmark
Mayo Clinic

Completed

FDG PET/MRI Evaluation of Facet Joint Pain

Low Back Pain

United States
University of California, Los Angeles
Centers for Medicare and Medicaid Services

Withdrawn

Molecular Cerebral Imaging in Incipient Dementia (MCI-ID) II

Mild Cognitive Impairment
Stanford University

Completed

Investigate Role of Metabolic Imaging in Predicting Tumor Response/Outcome After Pancreatic CA Tx

Pancreatic Cancer

United States
Cambridge University Hospitals NHS Foundation Trust

Recruiting

Sodium (23Na) MRI for Tumour Characterisation and Assessment of Therapy Response in Breast Cancer (NaRNIA)

Breast Cancer

United Kingdom
University of California, Los Angeles
Centers for Medicare and Medicaid Services

Completed

Metabolic Cerebral Imaging in Incipient Dementia (MCI-ID)

Dementia

United States
Ontario Clinical Oncology Group (OCOG)
Cancer Care Ontario

Active, not recruiting

Impact of Positron Emission Tomography (PET) Imaging in Muscle-invasive Urothelial Carcinoma of the Bladder Staging (PET MUSE)

Muscle-invasive Bladder Cancer

Canada
UNC Lineberger Comprehensive Cancer Center

Completed

Hybrid PET/MR in the Therapy of Cervical Cancer

Cervical Adenosquamous Carcinoma | Cervical Squamous Cell Carcinoma | Cervix Carcinoma

United States
Herlev Hospital

Completed

Diagnostic Imaging of Myeloma Bone Lesions (RAMP)

Multiple Myeloma

Denmark
Weill Medical College of Cornell University

Terminated

Dedicated Breast PET/MRI in Evaluation of Extent of Disease in Women With Newly Diagnosed Breast Cancer

Newly Diagnosed Breast Cancer

United States
Hospices Civils de Lyon

Completed

(18)F-FDG PET Database of Adult Healthy Individuals (BDD-FDG)

Healthy

France
Centre Georges Francois Leclerc

Recruiting

FCH vs FDG PET/CT in Detection of Lesions in Patients With Multiple Myeloma (MIM) (MIM)

Multiple Myeloma

France
University of Lausanne Hospitals
George Coukos, MD PhD, Head of oncology

Recruiting

68Ga-NODAGA-RGD PET/ CT for Tumoral Neoangiogenesis

Pathological Angiogenesis

Switzerland
University of Sao Paulo

Unknown

Use of Positron Emission Tomography/Computed Tomography (PET/CT) to Assess Tumor Response to Neoadjuvant Treatment for Distal Rectal Cancer

Rectal Cancer

Brazil
Yale University

Terminated

Methionine and PBR28-PET (Peripheral Benzodiazepine Receptors) in Brain Metastases Following Radiosurgery

Brain Metastasis

United States

Search clinical trials for: FDG-PET

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Cyprus

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations